Scientists at Boston Children’s Hospital are developing a PD-L1-boosting therapy to curb the wayward autoimmune reaction that causes Type 1 diabetes.

Scientists at MIT have developed nanoparticles that could eliminate the need to use viruses to edit genes.

Worm models show that a previously dismissed process in genetic coding could explain why quitting smoking is so hard.

A new pathway could be exploited to improve the efficacy of GLP-1 agonists in treating diabetes.

Part of an international initiative, a pan-European observational study aims to improve clinical care of traumatic brain injury.

The past week brought a link between glucose metabolism and Alzheimer's, discovery of two proteins key to TB, and a grant for male contraception.

Researchers in the U.K. tested AstraZeneca’s PARP inhibitor Lynparza and found it can penetrate the blood-brain barrier and invade glioblastoma tumors.

Scientists have discovered key stem cells that help the gecko tail regenerate—insights that may spur therapies for people with spinal cord injuries.